Aspen Aerogels, Inc. (NYSE:ASPN) Receives Average Recommendation of “Hold” from Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have earned an average rating of “Hold” from the nine ratings firms that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $12.6667.

ASPN has been the subject of several recent analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, December 29th. Canaccord Genuity Group reduced their price target on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Zacks Research upgraded shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th. Finally, Barclays reduced their target price on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a report on Friday, November 7th.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 56,845 shares of the firm’s stock in a transaction that occurred on Thursday, November 13th. The shares were sold at an average price of $3.23, for a total transaction of $183,609.35. Following the transaction, the chief executive officer directly owned 494,011 shares in the company, valued at approximately $1,595,655.53. This trade represents a 10.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 4.30% of the company’s stock.

Institutional Trading of Aspen Aerogels

Large investors have recently bought and sold shares of the business. Nisa Investment Advisors LLC grew its position in Aspen Aerogels by 1,094.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock worth $28,000 after purchasing an additional 4,390 shares during the last quarter. Balance Wealth LLC acquired a new stake in shares of Aspen Aerogels during the fourth quarter worth about $29,000. Jefferson Bridge Capital LLC purchased a new position in shares of Aspen Aerogels during the fourth quarter worth about $32,000. SBI Securities Co. Ltd. increased its position in Aspen Aerogels by 67.3% in the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock valued at $38,000 after acquiring an additional 2,551 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock valued at $43,000 after acquiring an additional 4,693 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Stock Up 5.4%

Shares of NYSE ASPN opened at $3.62 on Friday. The business has a 50-day moving average of $3.26 and a two-hundred day moving average of $5.64. The company has a market capitalization of $298.78 million, a price-to-earnings ratio of -0.97 and a beta of 2.94. Aspen Aerogels has a 1 year low of $2.80 and a 1 year high of $12.71. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The business had revenue of $73.02 million for the quarter, compared to analyst estimates of $73.42 million. Aspen Aerogels had a negative return on equity of 0.20% and a negative net margin of 86.52%.Aspen Aerogels’s revenue was down 37.8% on a year-over-year basis. During the same period last year, the business posted ($0.17) EPS. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.